Alzamend Neuro Inc (ALZN) Stock Price

2.35 ▲ +0.10 (+4.44%)
Open: 2.20 Vol: 83.9K Day's range: 2.132 - 2.40 Jan 16, 16:00 EST
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
ALZN Technical Analysis
5 mins 30 mins Hourly Daily Weekly
BUY BUY BUY BUY NEUTRAL
  5 mins 30 mins Hourly Daily Weekly
MA5 2.36▼ 2.36▼ 2.34▼ 2.31▲ 2.15▲
MA10 2.33▲ 2.33▲ 2.31▲ 2.28▲ 2.16▲
MA20 2.32▲ 2.33▲ 2.33▲ 2.15▲ 2.27▲
MA50 2.28▲ 2.22▲ 2.15▲ 2.19▲ 4.02▼
MA100 2.11▲ 2.08▲ 2.12▲ 2.30▲ 20.08▼
MA200 2.05▲ 2.14▲ 2.20▲ 3.19▼ 45.53▼
  5 mins 30 mins Hourly Daily Weekly
MACD 0.000▲ -0.006▼ -0.009▼ 0.032▲ 0.239▲
RSI 52.148▲ 54.009▲ 56.073▲ 59.026▲ 40.048▼
STOCH 76.746     77.222     54.949     85.285▲ 43.597    
WILL %R -46.667     -46.667     -46.667     -8.339▲ -33.350    
CCI 24.476     19.189     28.823     51.413     36.440    
Latest Filters Detected On ALZN
MA $ALZN Price Crossed Above MA(7) Set Alert
▼ GAP $ALZN Open Gap Down %2 Set Alert
CDL $ALZN Engulfing Candlestick Pattern Detected Set Alert
Alzamend Neuro Inc News
EXCLUSIVE: Alzamend Wraps Clinical Phase Of AL001 Study In Healthy Participants
Wednesday, November 19, 2025 06:30 AM
Alzamend Neuro, Inc. (NASDAQ: ALZN) on Wednesday announced the completion of the clinical portion of its first Phase 2 clinical study of AL001 in healthy human subjects. ALZN stock is racing ahead of ...
Alzamend Neuro Announces Completion of Clinical Portion of Phase II Clinical Trial of AL001 "Lithium in Brain" Study Conducted at Massachusetts General Hospital
Wednesday, November 19, 2025 05:00 AM
ATLANTA, Nov. 19, 2025 /PRNewswire/ -- Alzamend Neuro, Inc. (Nasdaq: ALZN) ("Alzamend"), a clinical-stage biopharmaceutical company focused on developing novel ...
EXCLUSIVE: Alzamend Wraps Clinical Phase Of AL001 Study In Healthy Participants
Tuesday, November 18, 2025 11:30 PM
In collaboration with Massachusetts General Hospital as the clinical trial site, Alzamend is investigating the distinctive characteristics of AL001. Alzamend Neuro AL001 (LiProSal) is a novel, ...
ALZN historical stock data
date open high low close volume
16/01/26 2.20 2.40 2.132 2.35 83,900
15/01/26 2.27 2.3294 2.24 2.25 19,730
14/01/26 2.35 2.369 2.266 2.27 24,200
13/01/26 2.37 2.41 2.33 2.37 63,200
12/01/26 2.41 2.41 2.20 2.33 43,400
09/01/26 2.33 2.40 2.254 2.39 83,100
08/01/26 2.34 2.35 2.293 2.34 41,600
07/01/26 2.14 2.35 2.129 2.34 124,100
06/01/26 2.06 2.135 2.00 2.13 44,000
05/01/26 1.93 2.069 1.93 2.05 71,000
Quote Details
52wk Low:1.691
52wk High:11.022
Vol:83.9K
Avg Vol(3m):1.3M
1Y Chng:-76.99%
1M Chng:+9.30%
Add to Watch List
More Information
Index US Composite
Market Cap. 8.93M